Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $2.68 Million - $3.64 Million
-209,400 Reduced 81.13%
48,700 $791,000
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $6.82 Million - $9.23 Million
-639,300 Reduced 71.24%
258,100 $3.64 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $1.9 Million - $2.49 Million
-234,000 Reduced 20.68%
897,400 $9.37 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $5.14 Million - $6.76 Million
714,200 Added 171.19%
1,131,400 $8.52 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $995,675 - $1.35 Million
119,100 Added 39.95%
417,200 $3.69 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $1.27 Million - $1.52 Million
-160,100 Reduced 34.94%
298,100 $2.72 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $1.66 Million - $2.89 Million
-241,800 Reduced 34.54%
458,200 $3.7 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.